WA
IBB icon

Waverly Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Waverly Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.99M Buy
52,515
+29,544
+129% +$5.08M 0.06% 296
2026
Q1 		$3.88M Sell
22,971
-215
-0.9% -$36.8K 0.03% 471
2025
Q4 		$3.91M Buy
23,186
+6,414
+38% +$1.04M 0.03% 425
2025
Q3 		$2.42M Buy
16,772
+432
+3% +$59K 0.02% 475
2025
Q2 		$2.07M Sell
16,340
-5,742
-26% -$705K 0.02% 485
2025
Q1 		$2.82M Buy
22,082
+62
+0.3% +$8.41K 0.03% 406
2024
Q4 		$2.91M Sell
22,020
-164
-0.7% -$23.1K 0.05% 313
2024
Q3 		$3.23M Buy
22,184
+99
+0.4% +$14.3K 0.06% 254
2024
Q2 		$3.03M Buy
22,085
+10,865
+97% +$1.45M 0.06% 251
2024
Q1 		$1.54M Buy
11,220
+5,006
+81% +$684K 0.04% 301
2023
Q4 		$844K Sell
6,214
-599
-9% -$73.1K 0.03% 239
2023
Q3 		$833K Buy
+6,813
New +$866K 0.04% 214
2022
Q2 		– Sell
-2,618
Closed -$341K – 214
2022
Q1 		$341K Hold
2,618
– – 0.03% 149
2021
Q4 		$341K Buy
2,618
+920
+54% +$142K 0.03% 148
2021
Q3 		$261K Hold
1,698
– – 0.02% 183
2021
Q2 		$288K Hold
1,698
– – 0.03% 157
2021
Q1 		$258K Sell
1,698
-500
-23% -$79.4K 0.03% 150
2020
Q4 		$373K Hold
2,198
– – 0.04% 109
2020
Q3 		$287K Buy
+2,198
New +$298K 0.04% 116
2014
Q1 		– Sell
-234
Closed -$18K – 767
2013
Q4 		$18K Hold
234
– – 0.01% 470
2013
Q3 		$16K Buy
+234
New +$15.3K 0.01% 385

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Waverly Advisors's IBB Position: Q2 2026 in Review

Waverly Advisors increased its iShares Biotechnology ETF (IBB) stake by 129% in Q2 2026, buying an estimated $5.08M and bringing the position to 52,515 shares worth $9.99M. The position accounts for 0.06% of the portfolio, ranked #296.

Waverly Advisors first reported a position in IBB in Q3 2013 and has held it in 21 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Waverly Advisors held 52,515 shares of iShares Biotechnology ETF worth $9.99M as of Q2 2026.
  • Waverly Advisors bought 29,544 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.08M.
  • iShares Biotechnology ETF made up 0.06% of Waverly Advisors's portfolio in Q2 2026, its #296 holding.
  • Waverly Advisors first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 21 quarters since.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.